Hemorrhagic shock is the leading cause of death in civilian and military trauma. Effective hemorrhage control and better resuscitation strategies have the potential of saving lives. However,ifnot performed properly, resuscitation can actually exacerbate cellular injury caused by hemorrhagic shock, and the type of fluid used for resuscitation plays an importantrole in this injury pattern. It is logical to preventthis cellular injury through wiser resuscitation strategies than attempting immunomodulation after the damage has already occurred. It is important to recognize that unlike numerous other variables, resuscitationi sc ompletely under our control.W ed ecide who, when and how should get resuscitated. This paper summarizes data from anumber of studies to illustrate the differential effects of commonly used resuscitation fluidsoncellular injury,and how these relatetoclinical practice. In addition, some novel resuscitation strategies are described that may become clinically available in the near future.
INTRODUCTION
Exsanguination and centraln ervous system (CNS) injuries aret he leading causes of deathi nc ivilian (1-2) as well as military trauma (3), and prompt hem orrhage control along with adequate fluid resuscita tion aret he key components of early trauma care. However,the optimal resuscitative strategy remains controversial: type of fluid, volume, rate, route of administration, and end points of resuscitation. This manuscriptd escribes some of the beneficial and ad verse effects of resuscitation fluids on cellularr e sponses, and how they may relate to our clinical prac tice.
EVOLUTION OF FLUID USE IN TRAUMA FLUID RESUSCITATION:EVOLVINg pARADIgM
It is now being recognizedt hat resuscitation fluids arenot completely innocuous, and they may actually potentiate the cellular injury caused by hemorrhagic shock. This concepto f" resuscitation injury" has steadilygained attention in recent years. Areport by the Institute of Medicine (1999) has described in de tail the wide spectrum of adverse consequences that can follow resuscitative efforts (4). The concept of large volume crystalloid resuscitation was aproduct of seminal work by Shires, Moyer,M oss and others during the 1960s (5-8), and it became common prac tice during the Vietnam conflict. Their work sugges ted that infusion of largevolumeisotonic crystalloids improved survival, and resuscitation fluids were needed not only to replace the intravascular volume loss, but also to replenish interstitial deficits. There fore, these investigators recommended fluid replace ment equal to three times the volume of blood loss (and as high as 8:1 for severeshock). At that time the emphasis was on restoration of intravascular and interstitial fluid deficits, without much importance attached to the cytotoxic effects of crystalloid fluids. Isotonic fluids wereu sed widely in Vietnam and it was during this period that the appearance of "shock lung/Da Nang lung" (later termed acute respiratory distress syndrome or ARDS) was first describedi n soldiers that received massive crystalloid resuscita tion. Today,ARDS and Multiple Organ Dysfunction Syndrome arem ajor causes of delayed mortality in trauma patients. Clinically,the role played by resus citation in the developmentofthese complications is difficult to establish due to ar emarkable paucity of prospective randomized trials in this area. However, an everincreasing basic science literatures upports the new paradigm that cellular injury is influenced not only by shock, but also by our resuscitation strat egies. Today,w ith the easy availability of advanced cellular research techniques, we can study the effect of resuscitation fluids on theb iological systems in much greaterdetail. Thesefindings now have practi cal implications as well. While some of the modified Ringer's solutions( ketone and pyruvate based) re maine xperimental, lactated Ringer's is now com mercially available in the conventional racemic for mulation or as apureLisomer solution, with mark edly different properties. Although it is not clearly known whether the attenuationo fc ellular injury markerss een in the preclinical studies would trans late into am easurable improvement in clinical out come in trauma patients, it remains an exciting pos sibility.
IS TRAUMA AN IMMUNE DISEASE?
Expertsi nt he field now tend to agree that serious traumatic and thermal injuries lead to immune dys function and subsequent cellular damage (9-10). Ac cording to this concept, trauma patients who survive the early postinjury period, enter ap hase of Sys temic InflammatoryR esponse Syndrome (SIRS), which in some patients leads to rapid onset of Mul tiple Organ Dysfunction Syndrome (MODS), with a high mortality rate. However,m ajority of seriously injured patients survive the initial SIRS response (without developing early MODS), and manifesta Compensatory Antiinflammatory Response Syn drome (CARS) with suppressed immunity and high chances of developing an infection. The resultantin fection can then lead to late MODS and death. A number of approaches have been tried to correct this posttraumatic immune dysfunction, with marginal results (11-13). However,am orel ogical approach would be to prevent the onset of immune dysfunc tion, rather than try to control multipleinterconnec ted cascades once they have been activated.
DOES EARLyFLUID RESUSCITATION IMpROVE SURVIVAL?
Althoughi ti sw idely believed that early aggressive fluid resuscitation is beneficial, clinical and basic sci ence literaturefails to provide conclusive supporting evidence (14-19). While analyzing the data, it is im portant to differentiate between the victims of blunt and penetrating trauma. As almost 20% of blunt trau ma patients can have associated traumatic braini n jury,a nd fluid resuscitation to prevent hypotension and secondary brain injury may be a logical approach in this group. However,this is not true in the setting of penetrating trauma. As am atter of fact, the basic rationale for administering intravenous fluids in pa tients with ongoingb leeding has been challenged repeatedly for almost ac entury (20). Theoretically, fluid resuscitation in the absence of (or prior to) hem orrhage control can exacerbate bleeding due to the disruption of early soft thrombus, coagulopathy,and hemodilution (21-24). Asystematicreview of 52 ani mal trials concludedthat fluid resuscitation appeared to decreasethe riskofdeath in modelsofseverehem orrhage (RR =0.48), but increased the risk of death in those with less severeh emorrhage (RR =1.86) (25). Furthermore,h ypotensive resuscitation, whenever tested,reduced the risk of death(RR =0.37). The proof of this concept in humans was publishedinthe New England Journalo fM edicinei n1 994 (26). In that study,h ypotensive patients with penetratingi njury to the torso wererandomized to routine fluid resus citation, or resuscitation was delayedu ntil bleeding had been surgically controlled. The results of this study demonstrated as urvival advantage in the de layed resuscitation group (70% versus 62%, p=0.04). This study has generated av igorous debate, and its findings have been extensivelyscrutinized for faults. Despite all the controversy,the most impressive find ing remains the fact that delaying fluid resuscitation did not increase the mortality in these patients. The issue of timing and volume of fluid resuscitation in bleeding patients has also been addressed by The Cochrane Database of Systematic Reviews (27). Only six randomizedclinical trails met the inclusion crite ria, and ac areful review failed to provide any evi dence in support of (or against) early or large volume intravenous fluid administration in uncontrolled hemorrhage. Based upon all this information, it is reasonable to conclude that fluid resuscitation is not as ubstitute for early hemorrhage control. Low vol ume, careful resuscitation is reasonable, especially when trying to get adying patient to definitivecare. However,e arly aggressive fluid resuscitation, in the absence to hemorrhage control, cannot be justified.
AggRESSIVEOR"SUpRANORMAL"RESUSCITATION
This concept gained momentumbased upon the work of Shoemaker and associates, who suggested that an oxygen debt builds up during shock which must be repaid by performing aggressive resuscitation in the intensive caresetting (28). To repay this tissue oxygen debt, cardiac outputsw erep ushed into "supranor mal" range (29) with volume loading,blood transfu sion, and inotropic drugs. This was continued until cardiac outputreached aplateau, or when the tissue oxygen consumption became independent of oxygen delivery.H owever,n umerous subsequent studies have failed to show an improvement in outcome with this approach (30-35). Aggressive fluid resuscitation on the other hand has been implicated in numerous postresuscitation complications such as Abdominal Compartment Syndrome (36-38). Therefore, despite its theoretical appeal this approach is no longer wid ely practiced.
IMpACT OF RESUSCITATION FLUIDS ON CELLULAR FUNCTIONS
Therei sn ow accumulating evidence that most cel lular functions areinfluenced by infusion of resusci tation fluids. Thereare anumber of key variables that govern the response, such as; 1) fluid composition, 2) fluid tonicity,3 )d uration of exposure, 4) type of cells that areexposed, 5) presence or absence of infec tion/inflammation, 6) presenceorabsenceofsecond hit, 7) timing of fluid administration. Although cel lular responses during the postresuscitation period involve almost all cell typest hrough multiple inter connectedcascades, for ease of presentation findings from selected studies have been summarized under some broad categories:
A) EFFECTS OF RESUSCITATION STRATEgIES ON NEUTROpHIL ExCITATION AND IMMUNE ACTIVATION IN VIVO
Neutrophil mediated tissue injury has been identified as akey mechanism of postresuscitation organ dam age (39). In as wine model of hemorrhagic shock, it has been shown that resuscitation with racemic lac tated Ringer's solution (DLLR, equal amounts of D and Lisomers of lactate) or merei nfusion of DLLR (without hemorrhage) caused an increase in neutro phil oxidative burst (40). In asimilar model, neutro phil excitation was influenced by the dose and rate of DLLR administration, and resuscitation with artifi cial colloids (Dextran and Hespan) had an even more pronounced effect on neutrophil excitation (41). On the other hand, no significant neutrophil excitation was seen in animals that werer esuscitated with hy pertonic saline, or fresh whole blood.
B) IMpACT OF RESUSCITATION FLUIDS ON HUMAN WHITE BLOOD CELLS (ExVIVO)
Similar to the animal data, exposureofhuman blood to isotonic crystalloidsand artificial colloids has been shown to cause an increase in oxidative burst, and the expression of adhesion molecules on the neutrophils in adose dependent fashion (42). Interestingly,inthis study natural colloids (albumin) did not excitet he neutrophils, and exposuretohypertonic saline (HTS) actually suppressed neutrophil functions. This sup pressive effect of hypertonic saline on neutrophil functions may be through the modulation of che moattractant receptor signaling pathways (43). When HTS is combined with dextran, the suppressive prop erties of HTS overcome the stimulatory properties of dextran (44). Response of cells to lactated Ringer's (LR) solution depends upon its composition. While conventional LR containing racemic lactate (D and Lisomer) is proinflammatory,s ubstitution of race mic lactatewith Lisomer of lactate, or ketone bodies (bhydroxybutyrate), can attenuate neutrophil activa tion and alter the expression of leukocyte genes known to be involved in inflammation, cell migra tion, and apoptosis(45). Using customized cDNA ar rays, we have shown that isotonic and hypertonic fluids do not differ in their effect on thec ytokine genes in human leukocytes( 46), buth ypertonicity decreases the expression of immune activation associ ated genes (47). Furthermore, the composition and tonicity of the resuscitation fluids can also have a dramatic influence on the life span of circulating cells (48).
C) DIFFERENTIAL EFFECTS OF RESUSCITATION FLUIDS ON MARKERS OF CELLULAR INJURyINV ARIOUS ORgANS
Once activated,n eutrophils bind to complimentary adhesion molecules (selectins, beta 2 integrins) on the endothelium beforet ransmigration into the tissues. It has been demonstrated that these adhesion mole cules areu pr egulated following resuscitation with racemic LR in ar odent model of hemorrhagic shock (49-50). Furthermore, in these studies LR resuscita tion was associated with histologic evidence of acute lung injury,w hereas none of these adverse findings werenoted following resuscitation with fresh whole blood. We know that injured cells undergo death via two distinct mechanisms: apoptosis and necrosis. Apoptosis, while morecontrolled, requires energy.In the absenceo fe nergy the cells may undergo death via the poorly controlled process of necrosis. Al thoughbalanced apoptosis is essential for homeosta sis and in the recovery from certain disease processes (51-54), am arked increase in apoptosis can be a marker of cellular injury and organ dysfunction (55-56). Using apoptosis as amarker of cellular injury,it has been shown that resuscitation with racemic LR results in increased apoptosis in intestinal mucosa, smooth muscle, liver (57), and lung (58) in rodents. pulmonarya nd hepatic apoptosis is markedly re duced if lactateinthe solution is substituted with b hydroxybutyrate (ketone Ringer's) or sodium pyru vate (pyruvate Ringer's) (59-61). Designer fluids containing other formulations of pyruvate(e.g. ethyl pyruvate) arealso superior to conventional solutions (62). In ar ecent study Shires (63) has confirmed that fluids differ dramatically in their capacity to induce tissue apoptosis,and that modified Ringer's solutions (ketone and bicarbonate Ringer's)cause significantly less apoptosis compared to the racemic LR. These findings noted in small animal models (rodents), have also been validated in ac linically relevant model of hemorrhage in swine, wherer esuscitation with con ventional LR solution increased apoptotic cell death in liver and lung (64). This was easily prevented by simple elimination of Dlactate from the Ringer's so lution. We now know that the modified Ringer's so lutions exert their protectivee ffectst hrough post translational modifications of key regulatory proteins (65), and by selective acetylation of histones (with subsequent alterationsingene transcription) (66). The impact of resuscitation strategies can also be seen in well protected sites such as the brain, wheret he physiologic state of the central nervous system cells can be altered by changing the composition of resus citation fluids (across the blood brain barrier) (67). Furthermore,r esuscitation influences not only the regulation and functions of cells but also the integ rity of the surrounding extracellular matrix (68).
D) EFFECT ON gENE REgULATION: INTEgRATED AppROACH TO DATA ANALySIS
Similar to the circulating cells, regulation of gene ex pression in thetissues is also influenced by resuscita tion strategies. We have discovered that~7% of genes in rats arealtered following shock and resuscitation. In each organ studied, the gene expression profile was dependent upon the fluid used for resuscitation (69). Although transcriptional profiling is now awell established technique, its application to systematic studying of various biological phenomena is still lim ited due to problems with highvolumedata analysis and interpretation. Interpretation of these largedata sets in the contextofaccumulatedknowledge on hu man functional networks could yield biologically meaningful information. Using this integrated ap proach to data analysis, ac omprehensive database has now been published, which further confirms that cellular mechanisms at the level of gene regulation areprofoundly influenced by shock, and by the choice of resuscitation strategy (70).
HypERTONIC SALINE
The use of HTS for resuscitation from hemorrhage was first describedi n1 980, when Ve lasco et al. (71), and DeFelippe et al. (72), reported in separate studies that hyperosmotic sodium chloride rapidlyexpands plasma volume after major blood loss. Becauseofits ability to mobilize interstitial fluids into the vascular space,250 ml of 7.5% saline can achieve results com parable to resuscitation with 2-3 litersof0.9% saline. Since the original reports, HTS has been used in a variety of circumstances and thousands of papers have appeared in the literature, including eight dou bleblinded randomized trials evaluating HTSor HTS withdextran(HSD)for prehospital or emergency de partment treatment of traumatic hypotension. Im proved rates of survival after discharge werer epor ted with HSDinseven of eight trials, althoughstatis tically significant improvement in overall survival was seen in only one trial. Am etaanalysis for the evaluation of HSD as the initial treatment for hypo volemic shock reviewed the original records from six trials (and 604 subjects) (73). Overall discharge sur vival rates wereb etter with HSD resuscitation as compared to conventional resuscitation. HSD resus citation was particularly effective for the subgroup of patientsthat had sustained head injury with adis charge survival rate of 38%, as compared to arate of 27% for the control group receiving saline. In the clinical literature, thereh as been ar emarkable ab sence of deleterious effects with HTS administration in morethan 1,000 trauma and surgical patients. No increase in the incidence of hypernatremic seizure, increased bleeding or blood transfusion requirement, coagulopathies, renal failure, cardiac arrhythmias, or central pontinem yelinolysis has been attributed to hypertonic resuscitation in traumap atients.T hese clinical trials had used HTS as av olume expander, but am orea dvantageous effect of HTS administra tion may be the attenuation of immune mediated cel lular injury.Anumber of preclinical studies have demonstrated that HTS has the potential to modulate the posttrauma immune response, with an overall attenuation of immune mediatedcellular injury (74-75). The salutary properties of hypertonic saline are primarily exerted through its effects on neutrophil endothelial interactions. For example, in addition to decreasing neutrophil excitation (40-42), HTS resus citation decreases inflammation (76), neutrophilen dothelial binding(77), lung damage (78), and bowel injury (79). Anumber of elegant studies have further elucidated the subcellular pathways that arei nflu enced by exposuret oh ypertonic saline (80-83).T he recently established Resuscitation Outcome Consor tium (ROC) (84), funded by the National Institutes of Health and the US Department of Defense is ready to start two multicenter trialso fh ypertonic resuscita tion in two populations of trauma patients to be con ducted simultaneously.Study1would determine the impact of hypertonic resuscitation on survivalf or blunt or penetrating traumapatients in hypovolemic shock,whereas Study 2wouldevaluate itsimpact on long term (6 month) neurologic outcome after severe traumatic brain injury.Both studies will be three arm, randomized, blinded intervention trials comparing hypertonic saline/dextran (7.5% saline/6% dextran 70,HSD), hypertonic saline alone (7.5% saline, HTS), and normal saline (NS) as the initial resuscitation fluid administered to these patientsinthe prehospital setting. In addition to the primary endpoints, com prehensive data about the immunologic consequen ces of hypertonic resuscitation would also be col lected. Hopefully,t hese studies would provide the conclusive evidence that is needed to get FDA ap proval for the routine use of HTS in the treatment of trauma patients.
CONSENSUS CONFERENCES
Control of hemorrhage and judicious resuscitation arec ritical elements of early battlefield care. How ever,t he optimal strategy for both of these goals is highly controversial due to ageneral lack of category I/II clinical evidence. In addition to clinical benefits, the militarymust also takeinto account the logistical aspects of the approach (weight, volume, storage re quirements etc). The Office of Naval Research (ONR) and the US Army Medical Research and Material Command (MRMC) have supported the basic re search in this field for many years. primarily as are sult of leadership and funding by the ONR, three significant consensus conferences wereh eld where data on fluid resuscitation was analyzed by experts, and recommendationsmade to improve clinical prac tice and to guide futurer esearch. The first meeting was under the supervision of the Institute of Medi cine (IOM) in 1998. The IOM report concluded that the current resuscitation strategies wereinadequate, potentially harmful, and needed radical changes. It identified numerous areas of futureresearch, and rec ommended that combat casualties should be resusci tated with 250 mL bolus of 7.5% saline (4). Unfortu nately the US Food and Drug Administration (FDA) has not yet approved this fluid for clinical use. In the followup meeting (June 2001, Uniformed Services University)an umber of clinical recommendations werem ade including: who should (and should not) be resuscitated, end point of resuscitation, as well as the optimalfluid (85). As the choice was deliberately limited to FDA approved agents(available in the US), Hetastarch (hydroxy ethyl starch, 500cc) was nar rowly recommended as the fluid of choice for use in the battlefield. In the third meeting (October 2001, Toronto, Canada) the scope was widened to include fluids that werea vailable in other NATO countries (even if not available in the United States) (86). At thismeeting acombination fluid (7.5% saline and 6% dextranhypertonics aline dextran) was recommen ded as the initial fluid of choice (87). At all of these meetingsexperts agreed that aggressive resuscitation is deleterious, an "ideal" fluid is yet not available, and that low volume resuscitation (hypertonic,c ol loid, or combination) is the most suitable choice for military needs. proceedings of the last two meetings have been published as as pecial supplement of the Journal of Trauma (May 2003), including the recom mendations for the initial fluid resuscitation of com bat casualties (88).
CHANgES IN CLINICAL RESEARCH AND pRACTICE OF RESUSCITATION.
The consensusconferences described heresystemati cally evaluated all the available data and made strong recommendations that have catalyzed an oticeable paradigm shift. For example, the US Armyand Navy have authorized the use of low volume resuscitation for combat casualty careand other NATO forces have developeds imilar protocols. The glaring absence of good clinical evidence has prompted collaboration between the National Institutes of Health and the US Department of Defense to establish ac onsortium of clinical centers for conductingresuscitation research. Hopefully,t his consortium will provide the much needed clinical data to validate and confirm the promising basic science findings. The resuscitation strategies that areb eing utilized by the US military in Iraq and Afghanistan already reflect the changing trends. Resuscitation in the combat zones is more se lective (fluids given only when needed), is low vol ume, and aims for practical endpoints (e.g. palpabe pulse). Colloid fluids (e.g. Hespan and Hextand) are replacing conventional crystalloidsfor early resusci tation thus minimizing the logistical burden. Also, early hemorrhage control is being prioritized over aggressive fluid resuscitation. It is too early to deter minethe direct impact of these new hemorrhage con trol and resuscitation strategies on combat casualty outcomes. However,i ti sv ery encouraging to note that for the first time since the Crimean war,the killed in action (KIA) rate has markedly dropped below the historic 20% to around 10-14% (89-90).
NOVEL RESUSCITATION STRATEgIES

pHARMACOLOgICAL RESUSCITATION
While resuscitation restores tissue perfusion, it does not have any specific antiinflammatory or prosur vival properties. In an attempt to improve the out come, investigators have added various protective agents to the resuscitation regimen with good results (91-94). An even moreexciting approach would be to improve survival through specific pharmacological agents without any fluid resuscitation, such as direct manipulation of gene transcription ("epigenetic code") to create apro-survival phenotype.Abrief description of the underlying mechanismsm ay help to clarify this concept.The key regulatory site of gene transcription (and subsequent downstream pathways) is located at the level of chromatin,a1 :1 complex of DNA and proteins, predominantly composed of histone pro teins. Various regulatory signals can affect gene tran scription by influencing the activity of histones, most notably through acetylation. The two enzymes that govern the process of acetylation areh istone acetyl transferase (HAT) (95), and histoned eacetylase (HDAC) (96-97). Modulation of the histone code is one of the most upstream cellular events, which si multaneously regulates asubset of genes that areco ordinately expressed to produce specific downstream effects. We have previously shown that hemorrhagic shock is associated withanimbalance in HAT/HDAC ratio, an altered acetylation pattern of histones, and adecrease in gene transcription potential (66). In that experiment,resuscitation reversed the shockinduced suppression of gene transcriptioni nafl uid specific fashion, i.e. each resuscitation fluid had adistinctive pattern of histone acetylation ("histone code"). Inter estingly,b rief administration of HDAC inhibitors in this model, during 45 minutes of resuscitation, was even moree ffective in reversing the shockinduced imbalance, and increasing acetylation of histones. The followup experiments have now established that di rectly targetingt he histones with HDAC inhibitors (HDACI), such as valproic acid (VpA,3 00 mg/kg) and suberoylanilide hydroxamic acid (SAHA), can rapidly correct shock induced alterations, and im prove survival in preclinical models of hemorrhage (98). Impressively,t his survival advantage was achieved without administration of any resuscitation fluids. The effect of hemorrhage and resuscitation on histone acetylation is almost identical in rodents and swine (99), and theoretically administration of HDACI should improve survival in large animal models in as imilar fashion (under investigation). This raises the possibilitythat cell survival, and ulti mately organism survival, can be improved through direct modulation of gene transcription in the setting of lethal hemorrhage. This exciting approach is cur rently being tested and refined under the Defense Advanced Research programs Agency (DARpA) "Surviving Blood Loss" program.
EMERgENCy pRESERVATION AND RESUSCITATION (EpR)
profound shock from blood loss does not respond well to conventional methods of resuscitation (100) . Even when the underlying cause can be treated and circulation restored, cerebral ischemia lasting5min utes or longer invariably results in severebrain dam age. Often the underlying injuries arer eparable but the patient dies of irreversible shock or severeb rain damage. In this setting, strategies to maintain cere bral and cardiac viability long enough to gain control of hemorrhage and restorei ntravascular volume could be lifesaving.T his requires an entirely new approach to the problem, with emphasis on rapid total bodyp reservation,r epairo fi njuriesd uring metabolic arrest, and controlled resuscitation: Emer gency preservation and Resuscitation (EpR). Cur rently,hypothermia is the most effective method for preserving cellularv iability during prolonged peri ods of ischemia. No clinical studies have been con ducted to test the therapeutic benefits of hypothermia in trauma patients. However,welldesigned preclini cal studies clearly support this concept. In exsangui nating cardiac arrest, rapid induction of deep/pro found hypothermia (<15°C) can improve the other wise dismal outcome (101) (102) (103) (104) . Dependingo nt he degree of hypothermia, good outcomes have been achieved with cardiac arrests of 15, 20, 30 and even 90 minutes in canine models (105) (106) (107) (108) . Furthermore, the period of hypothermia can be safelyextended to 180 minutes if blood is replaced with organ preserva tion fluids and low flow cardiopulmonary bypass is continued (as opposed to no flow) during the arrest period (109) . Although exciting, clinical relevance of theses tudiesw as limited by reliance on pressure controlled models of hemorrhagic shock (or no hem orrhage), an absence of major injuries, and lack of surgical interventions. Our group has testedthis con cept in clinically realistic large animal models of le thal vascular injuries and soft tissue trauma to dem onstrate that profound hypothermia can be induced through an emergency thoracotomy approach for to tal body protection ( 110) , with excellent longterm survival and no neurologicald amage or significant organ dysfunction. In afollowup study,itwas estab lished that lethal vascular injuries, above and below the diaphragm, can be repaired under hypothermic arrest with >75% long term survival (111) . Morei m portantly,itwas shown in that study that hypother mia could be used successfully even after 60 minutes of normothermic shock, and that the surviving ani mals werenot only neurologically intact but also had normal cognitive functions. Subsequent studies de terminedthat to achieve the best outcome profound hypothermia must be induced rapidly (2°C/minutes) and reversed at as lower rate (0.5°C/minutes) (112) (113) . Induction of hypothermia has been shown to preserve various cell types in the central nervous sys tem, in addition to providing some immunological advantages (114) (115) . The optimal depth of hypother mia is 10°C, and decreasing the temperaturetoultra profound levels (5°C) may actually worsen the sur vival (116) . Hypothermia can be induced using small portable equipment (suitable for austeres ettings) (117) . This is associated with excellent "total body preservation" which may have significant implica tions not only for treatmentoftraumatic injuries but also for preserving organs for transplant (118) . There is some early data from small animal models to sug gest that reversible metabolic arrest (and tissue pres ervation) can also be achieved with inhaled agents such as hydrogen sulfide (119) . It may sound futuris tic, but the expertiset op reserve the viability of key organs, during repair of otherwise lethal injuries is now available. Discussions arec urrently underway to design af easibility clinical trial to obtain transla tional data that may justify awider application of this approach in trauma practice.
CONCLUSIONS
An ideal fluid for the resuscitation of trauma victims should be safe, efficacious, cheap, easy to storea nd transport (especially important for the military), have the capacity to carry oxygen and nutrients to the cells, and should protectthe cells from resuscitation injury. Unfortunately, such afluid is not available today.Be cause of the emerging data on fluid cytotoxicity,w e should consider resuscitation fluids as drugs, with well defined indications and contraindications, safe dosages, and side effects. patient's response to trau ma is influencedbyanumber of variables (comorbid problems, severity of injuries, degree of shock, delay in definitive careetc). However,ascompared to most of the other variablesthat cannot be altered, resusci tative strategy is entirely under our control. We choose the natureo ft he fluids, their rate of administration, timing, and the end points of resuscitation. We also may decide not to resuscitateinselected patients.
Based on the work done in our laboratory and others, the effects of various resuscitation fluids on cellularfunctions can be summarized as follows:
ISOTONIC CRySTALLOIDS
Significant immune activation and induction of cel lular injury ares een with these fluids, especially ra cemic lactated Ringer's solution. We know that a very large number of trauma patients receive LR and do well clinically.H owever,t he patientst hat develop late complications of increased inflammatory re sponse areusuallythe ones that also have undergone severehemorrhagic shock and massive fluid resusci tation. Thus,L Rm ay be safe in small doses that the bodycan obviously tolerate, but not in larger amounts given over short periodsf ollowing hemorrhagic shock and trauma.Modifications of LR, such as elim ination of Dlactate can decrease these adverse ef fects, and complete substitution of lactate with other monocarboxytaes( e.g. ketone bodies or pyruvate) seems to be beneficial.
HypERTONIC CRySTALLOIDS
As compared to LR, hypertonic saline causes sup pression of neutrophil oxidative burst activity,d e creases neutrophilendothelial adhesions, and attenu ates immune mediated cellular injury.Because of its logistic advantages and immunologic benefits, HTS with or without acolloid seems to be the ideal fluid today for military application. However,amanufac turer will have to obtain FDA approval for its use as avolume expander in the USA. Although addition of dextrant oH TS tends to prolong the volume expan sion response, we feel that it might be easier to obtain FDA approval for as imple solution (HTS) than a combination solution (HTS and dextran). Studies scheduled to be performed under the NIH sponsored Resuscitation Outcome Consortium aree xpected to provide the conclusive evidence.
ARTIFICIAL COLLOIDS
Dextran and Hespan cause significant neutrophil ac tivation.H owever,c ombination of dextran with hy pertonic saline blunts this response. When given in combination, colloids also prolong the hemodynamic response of hypertonic saline resuscitation. pLASMA It has the most favorable effect on neutrophil activa tion as well as numerous markerso fc ellular injury. plasma is also av ery effective volume expander. However,ithas all the well recognizedproblems that area ssociated with storage, transport, and infusion of blood products. Autologous freeze dried plasma is apromisingalternative that can be reconstituted in a hyperoncotic, hypertonic fashion when needed. This is currently afocus of active investigations under the Department of Defense funded research programs.
FRESH WHOLE BLOOD
It is by far the best and most effective fluid for resus citation of hemorrhagic shock in animal models. Fresh whole blood is howevernot clinically available. Even if available, logistics of storagea nd transport make it an unrealistic option. One exception is the use of "walking blood bank" by the military,w here fresh whole blood is used in emergency situation. Thereiscurrently tremendous interest in investigat ing whether early use of whole blood (or components combined to create "whole blood") would benefitthe severely traumatized (120) .
ARTIFICIAL BLOOD
All the products testedtodate have failed to live up to expectations. However,t he rationale behind the development of safe and effective oxygen carrying resuscitation product is valid, and the results of an ongoing multiinstitutional phase III trial testing a human hemoglobin based solution areexpected come out in the near future.
pHARMACOLOgIC RESUSCITATION
Administering specific agents to protect against isch emiareperfusion injury,ortherapies that can induce ap rosurvival phenotype (through up regulation of selected genes) arevery attractive concepts.These are likely to be the next frontier in resuscitation research. In the future, severely traumatizedpatients arelikely to receive "designerfl uids" supplemented with a cocktailofagents specifically chosen to augment the intrinsicsurvival pathways.
EMERgENCy pRESERVATION AND RESUSCITATION
Viability of key organs can be maintained during 2-3 hours of arrest by early application of total body emergency preservation strategies. After repair of otherwisel ethal injuries, resuscitation can be per formed in ac ontrolled fashion. Therei sr apidly ac cumulating preclinicald ata to support this concept. Currently,induction of profound hypothermia is the most effective method to achieve this goal.
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